Public Health
(This August 31 story is refiled to add dropped word founding to Ertl’s title in paragraph 13) By Allison Martell and Julie Steenhuysen TORONTO/CHICAGO (Reuters) [more…]
(Reuters) - The modified common cold viruses behind high-profile COVID-19 vaccine candidates from China’s CanSino Biologics (6185.HK) and Russia’s Gamaleya Institute have been studied for [more…]
(Reuters) - New Jersey and California on Monday took a big step toward letting businesses resume their pre-pandemic lives, by allowing restaurants to begin limited [more…]
(Reuters) - AstraZeneca Plc said on Monday it has begun enrolling adults for a U.S.-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate. [more…]
(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines [more…]
MOSCOW (Reuters) - Russia reported 4,892 new cases of the novel coronavirus on Monday, pushing its tally so far to 927,745, the fourth largest in [more…]
PRAGUE (Reuters) - The Czech Republic’s overall number of coronavirus cases rose above 20,000, as the country tries to contain regional hotspots of the virus. [more…]